Karen Brunke
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Karen J.
Brunke is Chief Executive Officer at Magdalena Biosciences, Inc. since 2023.
Dr. Brunke is Independent Director at CytoDyn, Inc. since 2022.
Former roles include Chief Executive Officer at Cardeus Pharmaceuticals, Inc. from 2011 to 2014, Chief Operating Officer at Anexus Pharmaceuticals, and Executive VP-Corporate & Business Development at Jaguar Health, Inc. from 2021 to 2026.
Education includes undergraduate and doctorate degrees from the University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CYTODYN INC. -.--% | 20/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CYTODYN INC. | Directeur/Membre du Conseil | 01/04/2022 |
Magdalena Biosciences, Inc. | Directeur Général | 01/01/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| JAGUAR HEALTH, INC. | Corporate Officer/Principal | 01/01/2026 |
Cardeus Pharmaceuticals, Inc. | Directeur Général | 01/03/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
CytoDyn, Inc.
CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardeus Pharmaceuticals, Inc. | |
Jaguar Health, Inc.
Jaguar Health, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Magdalena Biosciences, Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national